Amylyx Pharmaceuticals, Inc.
- Stock
- Ticker AMLX
- Nasdaq
Performance, volatility and drawdowns of Amylyx Pharmaceuticals, Inc. since 01/2022, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $14,400. Global equities (VT): $14,690.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −96.0% in 06/2024, measured from the peak in 01/2023. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | -0.7 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – |
| Gross profit | -0.7 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – |
| Operating income | -41 | -38 | -43 | -36 | -37 | -44 | -46 | -50 |
| EBITDA | -40 | -38 | -43 | -36 | -36 | -44 | -46 | -50 |
| Net income | -38 | -36 | -41 | -34 | -33 | -41 | -43 | -45 |
| Earnings per share | -0.54 | -0.42 | -0.46 | -0.37 | -0.28 | -0.37 | -0.39 | -0.38 |
| Balance sheet | ||||||||
| Total assets | 194 | 220 | 195 | 363 | 333 | 294 | 265 | 787 |
| Liabilities | 29 | 18 | 27 | 31 | 27 | 20 | 25 | 33 |
| Equity | 165 | 201 | 168 | 332 | 305 | 273 | 239 | 754 |
| Cash | 77 | 60 | 58 | 225 | 227 | 229 | 49 | 240 |
| Cash flow | ||||||||
| Operating cash flow | -59 | -40 | -25 | -30 | -28 | -37 | -31 | -34 |
| Capital expenditure | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | – | – | 0.0 |
| Free cash flow | -59 | -40 | -25 | -30 | -28 | -37 | -31 | -34 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +219.6%, weakest 2024 at −74.3%. 1 of 3 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 5 Nov 2026 | −$0.38 |
| 6 Aug 2026 | −$0.39 |
| 7 May 2026 | −$0.37 |
| 3 Mar 2026 | −$0.28 |
| 6 Nov 2025 | −$0.37 |
| 7 Aug 2025 | −$0.46 |
| 8 May 2025 | −$0.42 |
| 4 Mar 2025 | −$0.54 |
| 7 Nov 2024 | −$1.07 |
| 8 Aug 2024 | −$1.07 |
| 9 May 2024 | −$1.75 |
| 22 Feb 2024 | $0.07 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €3.0bn
- Market cap in trading currency
- $3.35bn
- Enterprise value
- $2.58bn
- P/E
- –
- P/S
- –
- P/B
- 4.44
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -3.9%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- −$175m
- Net income
- −$163m
- Earnings per share
- −$1.42
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- -30.1%
- Return on assets
- -20.7%
Balance sheet and cash flow
- Cash
- $768m
- Cash per share
- $5.97
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 26.81
- Book value per share
- $5.86
- Operating cash flow
- −$130m
- Free cash flow
- −$130m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 129m
- Volume
- 1.14m
- Avg. volume 3 months
- 2.15m
- Relative volume
- 0.7
Price and technicals
- Price
- $26.02
- 1 day
- −0.7%
- 52-week high
- $39.66
- 52-week low
- $11.38
- Distance to 52-week high
- −34.4%
- Distance to 52-week low
- +128.6%
- Distance to 50-day line
- −10.4%
- Distance to 200-day line
- +23.2%
- RSI (14)
- 39
- Volatility 1M
- 61.7%
Performance
- 1 week
- −14.1%
- 1 month
- −8.9%
- 3 months
- −31.8%
- 6 months
- +91.6%
- YTD
- +115.4%
- 1 year
- +81.7%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has AMLX performed since 01/2022?
$10,000 grew to $14,400 by 20 Nov 2026, which is +7.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is AMLX?
Volatility was 104.1% per year, measured on monthly returns. The largest decline from a peak was −96.0%, with the low in 06/2024.
How does AMLX compare with a broad equity ETF?
Over the same period Global equities (VT) returned +8.2% per year at 15.4% volatility, AMLX returned +7.8% at 104.1%. The correlation of monthly returns was 0.02; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.